2012 Notch Signaling in Development, Regeneration & Disease Gordon Conference
2012 Notch Signaling in Development, Regeneration & Disease Gordon Conference
批准号:
8334175
负责人:
RAPHAEL KOPAN
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-13 至 2013-06-30
关键词:
AcademiaAddressAdultAgingAlagille SyndromeAlzheimer&aposs DiseaseAmericanAnimal ModelAntibodiesAreaAttentionBiochemistryBiologyBoxingCADASILCancer BiologyChronicClinicalCollaborationsCommunicationCommunitiesCoupledDevelopmentDevelopmental BiologyDevelopmental Cell BiologyDiseaseDrosophila genusDrug IndustryDysostosesEducationEnvironmentFutureGeneticGoalsHealthHeart ValvesHumanIndustryInternationalLeadershipLifeLocationMaineMalignant NeoplasmsMediator of activation proteinMemoryMultiple SclerosisMuscular DystrophiesNatural regenerationNervous system structureNotch Signaling PathwayOnset of illnessOrganOutcomeParticipantPathologyPathway interactionsPeptide HydrolasesPostdoctoral FellowReagentRelianceResearchResearch PersonnelScientistSignal PathwaySignal TransductionSolutionsStem cellsStudentsTechnologyTherapeuticThinkingTimeTissuesTravelWorkaortic valve disorderbasebody systemcancer initiationcancer preventioncancer therapycell typecollegecostdrug developmentexperiencefrontiergain of functionhuman diseaseinhibitor/antagonistinterestloss of functionmalformationmeetingsnotch proteinnovelsecretasesymposiumtumor
中文摘要
描述(由申请人提供):Notch信号在发展、再生和疾病中的首届会议将于2012年8月12日至17日在缅因州贝茨学院举行,该会议将解决美国科学界学术界和工业界尚未满足的需求。本次会议的广泛和长期目标是加强这一快速发展领域的跨学科讨论和合作,并更好地解决该领域从业者遇到的无数机械、发展、组织、临床和治疗方面的挑战。Notch信号通路是后生动物短距离细胞间通讯的中心介质,自1914年以来在果蝇中进行了研究,自1980年代以来在其他模式生物中进行了研究,自1991年以来在人类健康中进行了研究。如今,已经证实Notch活性的改变是几种发育综合征(Alagille、spondylostosis、主动脉瓣疾病)、成人发病疾病(CADASIL、各种心脏和瓣膜畸形、肌肉萎缩症、多发性硬化症)的基础,并以组织依赖的方式导致或促成癌症的发生、促进或进展。这些病理反映了功能的丧失(如Alagille, CADASIL)和功能的获得(如癌症)。由于Notch信号通路的独特之处在于它对蛋白酶的依赖,信号调节剂的缺乏,并且由于它在成人生活的许多器官中反复使用,Notch信号在疾病中的慢性管理之路被许多现有治疗方法的不良结果所掩盖。目前在抗肿瘤运动中实践的主要策略是基于g-分泌酶抑制剂或拮抗抗体;然而,由于它们在所有器官中不加区分地抑制Notch受体,这些试剂在慢性给药过程中被证明是有毒的。将对这一途径的兴趣扩展到发育生物学和癌症预防之外,是因为认识到阿尔茨海默病研究的一个巨大障碍是难以开发出能够抑制APP切割的可靠的Notch-sparing g-secretase抑制剂。解决这些难题需要“跳出框框”思考。这次跨学科但以途径为重点的会议的具体目标是汇集来自学术界、生物技术和制药行业的150名研究每种模式生物和几乎每种器官系统的科学家组成的多元化社区。参与者代表不同的方法来研究Notch在发育中的功能,其生物化学和遗传学;这将进一步促进发现和药物开发工作。这40位演讲者代表了世界各国的领导人,他们既有深厚的机构记忆,也有最新的演讲。重要的是,戈登会议的非正式和保密环境,以及为非正式互动提供的时间,将创造一个论坛,在这个论坛上,尖端技术、思想和发现可以自由交流,激发新的想法。最重要的是,GRC擅长整合学生、博士后和希望进入新领域的研究人员,比如研究这一重要的信号通路。
英文摘要
DESCRIPTION (provided by applicant): The inaugural Notch Signaling in Development, Regeneration & Disease meeting, to be held August 12-17, 2012 at Bates College, Maine, will address an unmet need in the American scientific community, both academic and industrial. The broad and long-term goal of this conference is to enhance cross-disciplinary discussions and collaborations in this rapidly expanding field and to better address the myriad of mechanistic, developmental, organismal, clinical and therapeutic challenges met by practitioners in the field. The Notch signaling pathway is a central mediator of short-range inter-cellular communication in metazoans, under study since 1914 in Drosophila, in other model organisms since the 1980's, and in human health since 1991. Today it is confirmed that alterations in Notch activity underlie several developmental syndromes (Alagille, Spondylocostal Dysostosis, aortic valve disease), adult onset diseases (CADASIL, various heart and valve malformations, muscular dystrophy, multiple sclerosis) and cause or contribute to cancer initiation, promotion or progression in a tissue-dependent manner. These pathologies reflect both loss of function (e.g., Alagille, CADASIL) and gain of function (e.g., cancer). Because the Notch signaling pathway is unique in its reliance on proteases, in the paucity of signal modulators, and because it is repeatedly used in many organs throughout adult life, the road to chronic management of Notch signaling in disease is obscured by many untoward outcomes with available therapies. The main strategy currently practiced in anti-tumor campaigns is based on g-secretase inhibitors or antagonistic antibodies; however, due to their indiscriminate inhibition of Notch receptors in all organs these reagents proved to be toxic during chronic administration. Expanding the interest in this pathway beyond developmental biology and cancer prevention is the realization that a great hurdle in Alzheimer's disease research is the difficulty in developing reliable Notch-sparing g-secretase inhibitors capable of inhibiting APP cleavage. Solving these puzzles requires "outside the box" thinking. The Specific Aims for this interdisciplinary yet pathway-focused meeting is to bring together a diverse community of 150 scientists working in every model organism and on nearly every organ system from academia, biotech and the pharmaceutical industry. The participants represent diverse approaches to study Notch function in development, its biochemistry and genetics; this will further facilitate discovery and drug development efforts. The 40 speakers represent world leaders with vast institutional memory as well as late-breaking presentations. Significantly, the informal and confidential environment in Gordon conferences, and the time provided for informal interactions, will create a forum in which cutting edge technologies, ideas and discoveries can be freely exchanged, stimulating new ideas. Most importantly, GRC excels in integrating students, postdocs and investigators wishing to enter a new field, such as the study of this important signaling pathway.
PUBLIC HEALTH RELEVANCE: The goal of the proposed Gordon Research Conference on Notch signaling in development, regeneration and disease is to provide a stimulating, international and cross disciplinary forum for the dissemination and discussion of new research, concepts and therapeutic opportunities at the forefront of Notch related biology. Alteration in Notch activity underlies or contributes to a growing list of developmental syndromes (Alagille, Spondylocostal Dysostosis, aortic valve disease), adult onset diseases (CADASIL, Alzheimer's disease, various heart and valve malformations, muscular dystrophy, multiple sclerosis) and cancers, expanding the interest in this pathway well beyond scientists interested in developmental and cell biology to those interested in stem cells, cancer biology and therapy. The meeting will bring together a diverse community of scientists working in every model organism and on nearly every organ system from academia, biotech and the pharmaceutical industry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Mechanism Regulating Renal Progenitor Aging
-
批准号:9103358
-
项目类别:
-
资助金额:$46.99万
-
财政年份:2016
-
负责人:RAPHAEL KOPAN
-
依托单位:
ASSESSING THE THERAPEUTIC WINDOW FOR FUTURE ANTI-NOTCH DIMERIZATION AGENTS
-
批准号:9064095
-
项目类别:
-
资助金额:$32.39万
-
财政年份:2013
-
负责人:RAPHAEL KOPAN
-
依托单位:
ASSESSING THE THERAPEUTIC WINDOW FOR FUTURE ANTI-NOTCH DIMERIZATION AGENTS
-
批准号:8577260
-
项目类别:
-
资助金额:$32.42万
-
财政年份:2013
-
负责人:RAPHAEL KOPAN
-
依托单位:
Imaging Vasular Tumors caused by Loss of Notch Function
-
批准号:8195495
-
项目类别:
-
资助金额:$11.93万
-
财政年份:2012
-
负责人:RAPHAEL KOPAN
-
依托单位:
2011 Epithelial Differentiation & Keratinization
-
批准号:8119177
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2011
-
负责人:RAPHAEL KOPAN
-
依托单位:
DEVELOPMENT OF SPLIT DAMID AS AN ALTERNATIVE METHODOLOGY TO CHROMATIN IMMUNOPRECI
-
批准号:7815022
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:RAPHAEL KOPAN
-
依托单位:
DEVELOPMENT OF SPLIT DAMID AS AN ALTERNATIVE METHODOLOGY TO CHROMATIN IMMUNOPRECI
-
批准号:7937828
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:RAPHAEL KOPAN
-
依托单位:
Proj 1: Imaging Notch Interations with Members of Its Pathway
-
批准号:7287030
-
项目类别:
-
资助金额:$24.57万
-
财政年份:2007
-
负责人:RAPHAEL KOPAN
-
依托单位:
Epidermal injury and TSLP
-
批准号:8701218
-
项目类别:
-
资助金额:$20.6万
-
财政年份:2006
-
负责人:RAPHAEL KOPAN
-
依托单位:
Epidermal injury and TSLP
-
批准号:8508647
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2006
-
负责人:RAPHAEL KOPAN
-
依托单位:
Epidermal injury and TSLP
-
批准号:8196224
-
项目类别:
-
资助金额:$24.25万
-
财政年份:2006
-
负责人:RAPHAEL KOPAN
-
依托单位:
Epidermal injury and TSLP
-
批准号:8378539
-
项目类别:
-
资助金额:$25.02万
-
财政年份:2006
-
负责人:RAPHAEL KOPAN
-
依托单位:
Mapping substrate/gamma-secretase interactions
-
批准号:7058244
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2005
-
负责人:RAPHAEL KOPAN
-
依托单位:
Mapping substrate/gamma-secretase interactions
-
批准号:7227758
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2005
-
负责人:RAPHAEL KOPAN
-
依托单位:
Mapping substrate/gamma-secretase interactions
-
批准号:6910061
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2005
-
负责人:RAPHAEL KOPAN
-
依托单位:
MAPPING SUBSTRATE/GAMMA-SECRETASE INTERACTIONS
-
批准号:6932225
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2005
-
负责人:RAPHAEL KOPAN
-
依托单位:
Mapping substrate/gamma-secretase interactions
-
批准号:7615642
-
项目类别:
-
资助金额:$29.15万
-
财政年份:2005
-
负责人:RAPHAEL KOPAN
-
依托单位:
Mapping substrate/gamma-secretase interactions
-
批准号:7409659
-
项目类别:
-
资助金额:$29.15万
-
财政年份:2005
-
负责人:RAPHAEL KOPAN
-
依托单位:
Role of Notch and Kidney Development
-
批准号:7416668
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2004
-
负责人:RAPHAEL KOPAN
-
依托单位:
ROLE OF NOTCH AND KIDNEY DEVELOPMENT
-
批准号:7654410
-
项目类别:
-
资助金额:$44.1万
-
财政年份:2004
-
负责人:RAPHAEL KOPAN
-
依托单位:
海外基金